List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 206 studies with search of: "Thrombocytopathy"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Cohort Study Comparing Short Daily Hemodialysis (HD) With Conventional HD
Conditions: End-Stage Renal Disease;   Thrombocytopathy;   Cardiovascular Diseases
Intervention:
2 Completed Treatment and Management of Women With Bleeding Disorders
Conditions: Menorrhagia;   Blood Coagulation Disorders;   Blood Platelet Disorders;   Von Willebrand Disease;   Hematologic Disease
Interventions: Drug: Tranexamic Acid;   Drug: Desmopressin Acetate
3 Recruiting Does An Abnormal PFA 100 Predict Bleeding After Renal Biopsy?
Conditions: Kidney Failure, Acute;   Kidney Failure, Chronic;   Blood Platelet Disorders;   Hemorrhage
Intervention: Device: measuring PFA-100 platelet function before kidney biopsy
4 Completed Platelet Aggregation Inhibition in Children on Clopidogrel (PICOLO)
Conditions: Congenital Heart Defects;   Blood Platelet Disorders
Intervention: Drug: Clopidogrel (SR25990)
5 Completed Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD)
Conditions: Von Willebrand Disease;   Blood Coagulation Disorders;   Blood Platelet Disorders;   Hematologic Disease
Intervention: Drug: Blood coagulation Factor VIII and vWF, human
6 Recruiting Sequestration of Platelets Prior to Bypass Reduces Bleeding After Cardiac Surgery
Conditions: Cardiac Surgical Procedures;   Cardiopulmonary Bypass;   Blood Platelet Disorders;   Blood Coagulation Disorders
Intervention: Procedure: Platelet rich plasma sequestration
7 Recruiting Optivate in People With Von Willebrand Disease Undergoing Surgery
Condition: Von Willebrand Disease
Intervention: Drug: Optivate
8 Recruiting Safety and Efficacy Study of PG2 to Treat Idiopathic Thrombocytopenic Purpura (ITP) Patients
Condition: Idiopathic Thrombocytopenic Purpura (ITP)
Intervention: Drug: PG2
9 Terminated Safety and Efficacy Study To Compare Uniplas With Cryosupernatant Plasma In Thrombotic Thrombocytopenic Purpura (TTP)
Condition: Thrombotic Thrombocytopenic Purpura (TTP)
Intervention: Drug: Uniplas
10 Completed Heparin Induced Thrombocytopenia: Pharmacoeconomics
Condition: Heparin Induced Thrombocytopenia (HIT)
Intervention:
11 Recruiting Phase 2, Pharmacokinetics Study of Eltrombopag in Japanese Thrombocytopenic Subjects With Chronic Liver Disease
Condition: Thrombocytopenia
Interventions: Drug: eltrombopag 25mg tablet;   Drug: eltrombopag 12.5mg tablet
12 Recruiting Platelet Function in Idiopathic Thrombocytopenic Purpura (ITP) Patients With Eltrombopag
Condition: Idiopathic Thrombocytopenic Purpura
Interventions: Drug: eltrombopag;   Drug: corticosteroids (Aprednislon)
13 Completed Drug Etiology of Aplastic Anemia and Related Dyscrasias
Conditions: Blood Disease;   Anemia, Aplastic;   Agranulocytosis;   Purpura, Thrombocytopenic
Intervention:
14 Recruiting Safety and Pregnancy Outcomes in Thrombocythemia Patients Exposed to Xagrid Compared to Other Treatments
Condition: Thrombocythemia, Essential
Intervention:
15 Completed Study of Higher Dose of Rituxan Versus Standard Doses of Rituxan With Cyclophosphamide, Vincristine, and Prednisone in Subjects With Chronic ITP
Condition: Immune Thrombocytopenic Purpura
Interventions: Drug: Rituxan and Cyclophosphamide, Vincristine and Prednisone;   Drug: Higher Dose of Rituximab
16 Active, not recruiting Safety and Efficacy Study of AMG 531 to Treat ITP in Pediatric Subjects
Conditions: Idiopathic Thrombocytopenic Purpura;   Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP);   Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Interventions: Drug: AMG 531;   Drug: Placebo
17 Completed Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic Purpura
Condition: Idiopathic Thrombocytopenic Purpura
Intervention: Drug: Immune Globulin Intravenous (Human), 10% Triple Virally Reduced Solution
18 Recruiting The Role of Endothelium Dysfunction in Progression of CKD (Chronic Kidney Disease) After AKI (Acute Kidney Injury)
Conditions: Acute Renal Failure;   Chronic Kidney Failure;   Endothelial Dysfunction;   Hemolytic-Uremic Syndrome (HUS)
Intervention:
19 Recruiting Clinical, Cellular, and Molecular Investigation Into Oculocutaneous Albinism
Conditions: Albinism;   Oculocutaneous Albinism;   Foveal Hypoplasia;   Hypopigmentation;   Nystagmus
Intervention:
20 Completed Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission
Conditions: Cancer-Related Problem/Condition;   Congenital Amegakaryocytic Thrombocytopenia;   Diamond-Blackfan Anemia;   Fanconi Anemia;   Leukemia;   Severe Congenital Neutropenia
Interventions: Biological: anti-thymocyte globulin;   Drug: busulfan;   Drug: fludarabine phosphate;   Procedure: allogeneic bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation;   Procedure: umbilical cord blood transplantation;   Radiation: radiation therapy

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services